Document is current
Any future updates will be listed below
-
Authors
Weiss, Jakob
Taron, Jana
Jin, Zexi
Mayrhofer, Thomas
Aerts, Hugo J. W. L.
Lu, Michael T.
Hoffmann, Udo
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation (WE 6405/2-1, TA 1438/1-2)
- License Information
-
More Information
Article History
Received: 18 December 2020
Accepted: 6 September 2021
First Online: 1 October 2021
Competing interests
: Dr. Lu has common stock in NVIDIA and AMD. Dr. Lu reported research funding as a co-investigator to MGH from Kowa Company Limited and Medimmune/Astrazeneca and receiving personal fees from PQBypass unrelated to this work. Dr. Aerts reported receiving personal fees from Sphera, Genospace, and Onc.AI outside the submitted work. Dr. Hoffmann reported receiving research support on behalf of his institution from Duke University (Abbott), HeartFlow, Kowa Company Limited, and MedImmune/Astrazeneca; and receiving consulting fees from Duke University (NIH), and Recor Medical unrelated to this research. Dr. Taron reported speakers bureau of Siemens Healthineers. Dr. Taron and Dr. Weiss are funded by an unrestricted fund from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; TA 1438/1-2 and WE 6405/2-1).
